Verrica Pharmaceuticals Inc. (VRCA) News
Track canonical SquawkNews coverage tagged to VRCA, Verrica Pharmaceuticals Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 3 indexed stories across 3 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
VRCA - Verrica Pharmaceuticals to Report Second Quarter 2026 Financial Results and Provide a Corporate Update on August 6, 2026 - Click For
VRCA - Verrica Pharmaceuticals to Report Second Quarter 2026 Financial Results and Provide a Corporate Update on August 6, 2026
EARNINGS | Jul 30, 2026, 12:01 PM UTC
H
VRCA Verrica Pharmaceuticals and medomie Pharma enter into exclusive distribution, marketing and supply agreement to commercialize ycanth® f
VRCA Verrica Pharmaceuticals and medomie Pharma enter into exclusive distribution, marketing and supply agreement to commercialize ycanth® for the treatment of molluscum contagiosum in Israel Verrica Pharmaceuticals: gra
GEOPOLITICS | Jul 21, 2026, 12:06 PM UTC
L
VRCA Begins COVE-3 Trial
Verrica Pharmaceuticals announces the first US patient dosed in the COVE-3 trial for YCANTH to treat common warts
EQUITY | Jun 22, 2026, 12:05 PM UTC